Module

Promising Investigational Directions: An Overview of Targeted Therapy in GBM

Source: Current Research Directions in Glioblastoma Multiforme: Evolutions in Targeted Therapy

Promising Investigational Directions: An Overview of Targeted Therapy in GBM

Program Director: James J. Vredenburgh, MD

Faculty:

Henry S. Friedman, MD

CREDIT INFORMATION

Release Date: November 25, 2008

Expiration Date: November 24, 2009

Physicians: maximum of 0.75 AMA PRA Category 1 Credits™

Status: The activity is not currently available for credit.

Learning Objectives

Upon completion of this activity, participants should be able to:

Discuss current approaches to the treatment of glioblastoma multiforme including chemotherapy, surgical and radiation therapeutic approaches
Describe the molecular targets of glioblastoma multiforme
Recount research directions with targeted agents demonstrating investigational potential for the treatment of glioblastoma multiforme

Topics covered include:

Introduction
EGFR Inhibitors
Antiangiogenic Therapy
Platelet-Derived Growth Factor Receptor Inhibitors
Mammalian Target of Rapamycin Inhibitors
Proteasome Inhibitors
PKC Inhibitors
Farnesyltransferase Inhibitors
Histone Deacetylase Inhibitors
Summary

Disclaimer: The materials published on the Clinical Care Options Sites reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.